Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1636 AL 1650

Blood-based biomarkers in Alzheimer's disease: a mini-review

Padala SP, Newhouse PA.

Metab Brain Dis. 2023 Jan;38(1):185-193. doi: 10.1007/s11011-022-01114-1. Epub 2022 Nov 7.

Metal-organic frameworks: A promising option for the diagnosis and treatment of Alzheimer's disease

Tajahmadi S, Molavi H, Ahmadijokani F, Shamloo A, Shojaei A, Sharifzadeh M, Rezakazemi M, Fatehizadeh A, Aminabhavi TM, Arjmand M.

J Control Release. 2023 Jan;353:1-29. doi: 10.1016/j.jconrel.2022.11.002. Epub 2022 Nov 21.

Omics-based biomarkers discovery for Alzheimer's disease

Aerqin Q, Wang ZT, Wu KM, He XY, Dong Q, Yu JT.

Cell Mol Life Sci. 2022 Nov 8;79(12):585. doi: 10.1007/s00018-022-04614-6.

Driving assessment in preclinical Alzheimer's disease: progress to date and the path forward

Bayat S, Roe CM.

Alzheimers Res Ther. 2022 Nov 8;14(1):168. doi: 10.1186/s13195-022-01109-1.

Overview of the blood biomarkers in Alzheimer's disease: Promises and challenges

Delaby C, Hirtz C, Lehmann S.

Rev Neurol (Paris). 2023 Mar;179(3):161-172. doi: 10.1016/j.neurol.2022.09.003. Epub 2022 Nov 10.

PET molecular imaging for pathophysiological visualization in Alzheimer's disease

Wang J, Jin C, Zhou J, Zhou R, Tian M, Lee HJ, Zhang H.

Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):765-783. doi: 10.1007/s00259-022-05999-z. Epub 2022 Nov 14.

Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk: Study protocol for a pilot randomized controlled trial

Mossavar-Rahmani Y, Shaw PA, Hakun JG, Katz MJ, Wylie-Rosett J, Sliwinski MJ.

Contemp Clin Trials. 2023 Jan;124:107006. doi: 10.1016/j.cct.2022.107006. Epub 2022 Nov 14.

Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential

Olichney J, Xia J, Church KJ, Moebius HJ.

Neural Plast. 2022 Nov 8;2022:2104880. doi: 10.1155/2022/2104880. eCollection 2022.

Blood and Cerebrospinal Fluid Biomarkers in Vascular Dementia and Alzheimer's Disease: A Brief Review

Gorelick PB.

Clin Geriatr Med. 2023 Feb;39(1):67-76. doi: 10.1016/j.cger.2022.08.001. Epub 2022 Oct 18.

Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review

Santos F, Cabreira V, Rocha S, Massano J.

J Geriatr Psychiatry Neurol. 2023 Jul;36(4):267-281. doi: 10.1177/08919887221141651. Epub 2022 Nov 24.

β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease

Mohaupt P, Pons ML, Vialaret J, Delaby C, Hirtz C, Lehmann S.

Alzheimers Res Ther. 2022 Nov 30;14(1):179. doi: 10.1186/s13195-022-01125-1.

Role of non‑coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)

Pierouli K, Papakonstantinou E, Papageorgiou L, Diakou I, Mitsis T, Dragoumani K, Spandidos DA, Bacopoulou F, Chrousos GP, Goulielmos GΝ, Eliopoulos E, Vlachakis D.

Int J Mol Med. 2023 Jan;51(1):5. doi: 10.3892/ijmm.2022.5208. Epub 2022 Dec 1.

Multiparametric Quantitative Imaging Biomarker as a Multivariate Descriptor of Health: A Roadmap

Raunig DL, Pennello GA, Delfino JG, Buckler AJ, Hall TJ, Guimaraes AR, Wang X, Huang EP, Barnhart HX, deSouza N, Obuchowski N.

Acad Radiol. 2023 Feb;30(2):159-182. doi: 10.1016/j.acra.2022.10.026. Epub 2022 Dec 1.

How far is the goal of applying β-amyloid in cerebrospinal fluid for clinical diagnosis of Alzheimer's disease with standardization of measurements?

Zou Y, Yu S, Ma X, Ma C, Mao C, Mu D, Li L, Gao J, Qiu L.

Clin Biochem. 2023 Feb;112:33-42. doi: 10.1016/j.clinbiochem.2022.11.013. Epub 2022 Dec 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias